![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Brain Cancer Survival Improved Following FDA Approval of Bevacizumab
Brain Cancer Survival Improved Following FDA Approval of Bevacizumab
August 20, 2013
A new study shows that glioblastoma patients who died after FDA approval of bevacizumab ultimately lived longer than those who died of the disease prior to approval.
Newswise
Newswise
Upcoming Events
-
21Oct